Search Results - "Bailey, Sarah K."

  • Showing 1 - 17 results of 17
Refine Results
  1. 1

    Inhibition of Hedgehog signaling reprograms the dysfunctional immune microenvironment in breast cancer by Hanna, Ann, Metge, Brandon J., Bailey, Sarah K., Chen, Dongquan, Chandrashekar, Darshan S., Varambally, Sooryanarayana, Samant, Rajeev S., Shevde, Lalita A.

    Published in Oncoimmunology (04-03-2019)
    “…Host responses to tumor cells include tumor suppressing or promoting mechanisms. We sought to detail the effect of Hedgehog (Hh) pathway inhibition on the…”
    Get full text
    Journal Article
  2. 2

    Deficiency of tumor suppressor Merlin facilitates metabolic adaptation by co-operative engagement of SMAD-Hippo signaling in breast cancer by Mota, Mateus S V, Jackson, William P, Bailey, Sarah K, Vayalil, Praveen, Landar, Aimee, Rostas, Jack W, Mulekar, Madhuri S, Samant, Rajeev S, Shevde, Lalita A

    Published in Carcinogenesis (New York) (21-09-2018)
    “…Merlin deficiency elicits the co-operative activity of the Hippo and TGF-β pathways to disengage restriction on STAT3 and hexokinase 2, enabling a metabolic…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Induction of KLF4 in basal keratinocytes blocks the proliferation-differentiation switch and initiates squamous epithelial dysplasia by FOSTER, K. Wade, ZHAOLI LIU, KUDLOW, Jeffrey E, LOBO-RUPPERT, Susan M, RUPPERT, J. Michael, NAIL, Clinton D, XINGNAN LI, FITZGERALD, Thomas J, BAILEY, Sarah K, FROST, Andra R, LOURO, Iuri D, TOWNES, Tim M, PATERSON, Andrew J

    Published in Oncogene (24-02-2005)
    “…KLF4/GKLF normally functions in differentiating epithelial cells, but also acts as a transforming oncogene in vitro. To examine the role of this zinc finger…”
    Get full text
    Journal Article
  5. 5

    O-GlcNAcylation of GLI transcription factors in hyperglycemic conditions augments Hedgehog activity by Das, Shamik, Bailey, Sarah K., Metge, Brandon J., Hanna, Ann, Hinshaw, Dominique C., Mota, Mateus, Forero-Torres, Andres, Chatham, John C., Samant, Rajeev S., Shevde, Lalita A.

    Published in Laboratory investigation (01-02-2019)
    “…Modification of proteins by O-linked β-N-acetylglucosamine (O-GlcNAc) promotes tumor cell survival, proliferation, epigenetic changes, angiogenesis, invasion,…”
    Get full text
    Journal Article
  6. 6

    microRNA-29 negatively regulates EMT regulator N-myc interactor in breast cancer by Rostas, 3rd, Jack W, Pruitt, Hawley C, Metge, Brandon J, Mitra, Aparna, Bailey, Sarah K, Bae, Sejong, Singh, Karan P, Devine, Daniel J, Dyess, Donna L, Richards, William O, Tucker, J Allan, Shevde, Lalita A, Samant, Rajeev S

    Published in Molecular cancer (29-08-2014)
    “…N-Myc Interactor is an inducible protein whose expression is compromised in advanced stage breast cancer. Downregulation of NMI, a gatekeeper of epithelial…”
    Get full text
    Journal Article
  7. 7

    Loss of tumor suppressor Merlin results in aberrant activation of Wnt/β-catenin signaling in cancer by Morrow, K Adam, Das, Shamik, Meng, Erhong, Menezes, Mitchell E, Bailey, Sarah K, Metge, Brandon J, Buchsbaum, Donald J, Samant, Rajeev S, Shevde, Lalita A

    Published in Oncotarget (05-04-2016)
    “…The expression of the tumor suppressor Merlin is compromised in nervous system malignancies due to genomic aberrations. We demonstrated for the first time,…”
    Get full text
    Journal Article
  8. 8

    Loss of Merlin induces metabolomic adaptation that engages dependence on Hedgehog signaling by Das, Shamik, Jackson, William P., Prasain, Jeevan K., Hanna, Ann, Bailey, Sarah K., Tucker, J. Allan, Bae, Sejong, Wilson, Landon S., Samant, Rajeev S., Barnes, Stephen, Shevde, Lalita A.

    Published in Scientific reports (23-01-2017)
    “…The tumor suppressor protein Merlin is proteasomally degraded in breast cancer. We undertook an untargeted metabolomics approach to discern the global…”
    Get full text
    Journal Article
  9. 9

    Identification of initial leads directed at the calmodulin-binding region on the Src-SH2 domain that exhibit anti-proliferation activity against pancreatic cancer by Tzou, Ywh-Min, Bailey, Sarah K., Yuan, Kaiyu, Shin, Ronald, Zhang, Wei, Chen, Yabing, Singh, Raj K., Shevde, Lalita A., Rama Krishna, N.

    Published in Bioorganic & medicinal chemistry letters (15-02-2016)
    “…[Display omitted] Cellular calmodulin binds to the SH2 domain of Src kinase, and upon Fas activation it recruits Src into the death-inducing signaling complex…”
    Get full text
    Journal Article
  10. 10

    Epithelial transformation by KLF4 requires Notch1 but not canonical Notch1 signaling by Liu, Zhaoli, Teng, Lihong, Bailey, Sarah, Frost, Andra R., Bland, Kirby I., LoBuglio, Albert F., Ruppert, J. Michael, Lobo-Ruppert, Susan M.

    Published in Cancer biology & therapy (01-10-2009)
    “…The transcription factors Notch1 and KLF4 specify epithelial cell fates and confer stem cell properties.  Suggesting a functional relationship, each gene can…”
    Get full text
    Journal Article
  11. 11

    KLF4 and PCNA identify stages of tumor initiation in a conditional model of cutaneous squamous epithelial neoplasia by Huang, Conway C., Liu, Zhaoli, Li, Xingnan, Bailey, Sarah, Nail, Clinton D., Foster, K. Wade, Frost, Andra R., Ruppert, J. Michael, Lobo-Ruppert, Susan M.

    Published in Cancer biology & therapy (01-12-2005)
    “…KLF4 is induced upon growth-arrest in vitro and during epithelial maturation in vivo, and is essential for proper cell fate specification of post-mitotic…”
    Get full text
    Journal Article
  12. 12

    Prevention of KLF4-mediated tumor initiation and malignant transformation by UAB30 rexinoid by Jiang, Wen, Deng, Wentao, Bailey, Sarah, Nail, Clint D., Frost, Andra R., Brouillette, Wayne J., Muccio, Donald D., Grubbs, Clinton J., Lobo-ruppert, Susan M, Ruppert, J. Michael

    Published in Cancer biology & therapy (01-02-2009)
    “…The transcription factor KLF4 functions in post-mitotic epithelial cells to promote differentiation, and functions in a context-dependent fashion as an…”
    Get full text
    Journal Article
  13. 13

    Abstract 657: N-Myc and STAT Interactor knock out in the mammary epithelium prompts hyper-proliferation by Pruitt, Hawley C., Metge, Brandon J., Bailey, Sarah K., Shevde, Lalita A., Samant, Rajeev S.

    Published in Cancer research (Chicago, Ill.) (15-07-2016)
    “…Abstract N-Myc and STAT Interactor (NMI) is an evolutionarily conserved protein that is widely expressed in fetal and adult tissues. Early studies implicated…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Snail induction is an early response to Gli1 that determines the efficiency of epithelial transformation by LI, X, DENG, W, NAIL, C. D, BAILEY, S. K, KRAUS, M. H, RUPPERT, J. M, LOBO-RUPPERT, S. M

    Published in Oncogene (26-01-2006)
    “…Gli family members mediate constitutive Hedgehog signaling in the common skin cancer, basal cell carcinoma (BCC). Snail/Snai1 is rapidly induced by Gli1 in…”
    Get full text
    Journal Article
  16. 16

    Abstract 2466: The tumor suppressor Merlin decreases TGFβ/Smad signaling in metastatic breast cancer cells by Jackson, William P., Kreitzburg, Kelly M., Das, Shamik, Bailey, Sarah K., Metge, Brandon J., Samant, Rajeev S., Shevde-Samant, Lalita R.

    Published in Cancer research (Chicago, Ill.) (01-10-2014)
    “…Abstract Background: Merlin is a tumor suppressor protein encoded by the NF2 gene. Mutations in NF2 have been implicated in neurofibromas, schwannomas, and…”
    Get full text
    Journal Article
  17. 17

    Abstract 4010: MicroRNA regulator of NMI: implications for breast cancer by Pruitt, Hawley C., III, Jack W. Rostas, Metge, Brandon J., Devine, Daniel J., Bailey, Sarah K., Shevde, Lalita A., Samant, Rajeev

    Published in Cancer research (Chicago, Ill.) (01-10-2014)
    “…Abstract Recent investigations by our laboratory have demonstrated that NMI expression is down-regulated in patient breast tumors, especially those displaying…”
    Get full text
    Journal Article